Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 10OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Papillomavirus Infections 1Neoplasms 1Cancer Survivor 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Vaccines, Synthetic × Clear all
NCT05435209 2023-11-29

Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents

University of Washington

Phase 4 Completed
158 enrolled

Papillomavirus Infections

NCT05149248 2021-12-08

CONDESA

Instituto Nacional de Salud Publica, Mexico

Phase 2/3 Completed
6,000 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT01492582 2021-10-27

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

University of Alabama at Birmingham

Phase 2 Completed
1,499 enrolled 11 charts

Cancer Survivor

NCT00524745 2017-04-14

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

PATH

Phase NA Completed
903 enrolled 10 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡